Somagenetix

Developer of gene therapies to treat inherited immune diseases

placeZurich, Zurich, Switzerland calendar_todayFounded 2018 groups3 employees language somagenetix.com

Social engagement

Social engagement: 924 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include VI Partners.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

30 Mar 2026 · Manufacturing Team Member Stem Cell Processing · Zurich, Zurich

Based on job postings tracked across public sources.

Coming soon